Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Pharmaceuticals 1
(
Latest Titles
)
Pharmaceuticals 2
Pharmaceuticals 3
Pharmaceuticals 4
Pharmaceuticals 5
-
Drug Discovery
<< You are in This Category
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
A Concise Guide to Clinical Trials
static version
printer friendly
pdf version
A Guide to Business & Regulatory Strategies: Companion Diagnostic Prod...
static version
printer friendly
A Guide to Evaluating and Choosing CROs
static version
printer friendly
pdf version
A Product Director’s Guide to Promotional Mix
static version
printer friendly
pdf version
Accelerating Lead Generation: Emerging Technologies and Strategies
static version
printer friendly
pdf version
Achieving Market Dominance Through Reformulation: A Strategic Insight
static version
printer friendly
Advances in RNAi--A Global Technology Assessment (Technical Insights)
static version
printer friendly
pdf version
Advancing Drug Discovery Through Structure-Guided Drug Design
static version
printer friendly
Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery
static version
printer friendly
pdf version
Analysis of Prostate Cancer R&D: The Complete Guide
static version
printer friendly
Angiogenesis Modulators: Strategies for Drug Discovery
static version
printer friendly
pdf version
Angiotensin as a target for the treatment of Alzheimer's disease, anxi...
static version
printer friendly
Antibiotics and Drug Resistance
static version
printer friendly
pdf version
Antibody Therapeutics: Product Development, Market Trends, and Strateg...
static version
printer friendly
pdf version
Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets...
static version
printer friendly
pdf version
Antisense Therapy: Technical Aspects and Commercial Opportunities
static version
printer friendly
Applications of Stem Cells in Drug Discovery
static version
printer friendly
Assay Development and Technologies, 2nd Edition
static version
printer friendly
pdf version
Aurora Kinase inhibitors - The dawn of a new approach to cancer
static version
printer friendly
Autoimmune Treatment (2009 - 2014)
static version
printer friendly
pdf version
^ Top
B
Bio/Pharma R&D Statistical Sourcebook 2008/2009
static version
printer friendly
pdf version
Biochips in Drug Discovery in Europe
static version
printer friendly
pdf version
Biomanufacturing Strategies: Market Drivers, Build-vs-Buy Decisions an...
static version
printer friendly
pdf version
Biomarkers: The Future of Next-Generation Drug R&D
static version
printer friendly
pdf version
BioMed Outsourcing Report-Drug Discovery Partnerships-The Indian Bioph...
static version
printer friendly
Biomed Outsourcing Report: Drug Discovery and Development Partnerships...
static version
printer friendly
Biopartnering Strategies: Maximizing returns from biotechnology deal-m...
static version
printer friendly
pdf version
Biosimilars Series: Strategic Issues - Potential Remains Uncertain
static version
printer friendly
pdf version
Booming Global Obesity Drug Market
static version
printer friendly
pdf version
Building on Early Successes of Immunomodulators in the Fight Against C...
static version
printer friendly
pdf version
^ Top
C
c-MET/HGF Inhibitors – Target and Company Pipelines
static version
printer friendly
pdf version
Cancer Drug Discoveries: What the Future Holds
static version
printer friendly
Cancer Vaccine Developments to 2013 + Cancer Vaccine Tracker
static version
printer friendly
pdf version
Cell-Based Assays for Drug Discovery
static version
printer friendly
pdf version
Chemical Genetics in Drug Discovery
static version
printer friendly
pdf version
Clinical Trials Handbook
static version
printer friendly
pdf version
Clinical Trials in India
static version
printer friendly
pdf version
Clinical Trials in Poland 2008. Development Forecasts for 2008-2010
static version
printer friendly
pdf version
Clinical Trials in Poland 2008. Development Forecasts for 2008-2010
static version
printer friendly
pdf version
Clinical Trials in Russia 2008. Russia Compared to Other Countries
static version
printer friendly
pdf version
Clinical Trials Market in Russia
static version
printer friendly
pdf version
Clinical Trials: Exploring Wireless Opportunities
static version
printer friendly
CNS Drug Discoveries: Alzheimer's Disease Chapter
static version
printer friendly
pdf version
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder Chapter...
static version
printer friendly
pdf version
CNS Drug Discoveries: Depression Chapter
static version
printer friendly
pdf version
CNS Drug Discoveries: Multiple Sclerosis Chapter
static version
printer friendly
pdf version
CNS Drug Discoveries: Parkinson's Disease Chapter
static version
printer friendly
pdf version
CNS Drug Discoveries: Schizophrenia Chapter
static version
printer friendly
pdf version
CNS Drug Discoveries: What the Future Holds 2008
static version
printer friendly
pdf version
Commercial and Pipeline Insight: Infertility - Optimizing a market bou...
static version
printer friendly
pdf version
Commercial Insight: Antidiabetics - Billion Dollar Drugs, Pipeline Dre...
static version
printer friendly
Commercial Insight: Upper GI Disorders - Innovation needed to overcome...
static version
printer friendly
pdf version
Commercial Opportunities from Biomarkers: Transforming drug discovery,...
static version
printer friendly
pdf version
Competition Driving Breakthroughs in Sports Medicine Market
static version
printer friendly
pdf version
Competitor Analysis: Alzheimer’s Disease Antibodies
static version
printer friendly
pdf version
Competitor Analysis: Antithrombotics
static version
printer friendly
pdf version
Competitor Analysis: Antiviral Antibodies
static version
printer friendly
pdf version
Competitor Analysis: Cannabinoid CB1 Receptor Antagonists
static version
printer friendly
pdf version
Competitor Analysis: CD20 Antibodies
static version
printer friendly
pdf version
Competitor Analysis: Diabetes Drug Pipeline
static version
printer friendly
pdf version
Competitor Analysis: Dipeptidyl Peptidase IV (DPP-IV) Inhibitors
static version
printer friendly
pdf version
Competitor Analysis: Emerging Diabetes Drugs
static version
printer friendly
pdf version
Competitor Analysis: Enzyme Replacement Therapies
static version
printer friendly
pdf version
Competitor Analysis: Follicle Stimulating Hormone (FSH)
static version
printer friendly
pdf version
Competitor Analysis: GLP-1 Receptor Agonists
static version
printer friendly
pdf version
Competitor Analysis: HDL Raising Therapies
static version
printer friendly
pdf version
Competitor Analysis: Human Growth Hormone (hGH)
static version
printer friendly
pdf version
Competitor Analysis: Immunotherapy of S. aureus Infections
static version
printer friendly
pdf version
Competitor Analysis: Insulin
static version
printer friendly
pdf version
Competitor Analysis: Integrin Antagonists
static version
printer friendly
pdf version
Competitor Analysis: Interferon
static version
printer friendly
pdf version
Competitor Analysis: Janus Kinase (JAK) Inhibitors
static version
printer friendly
pdf version
Competitor Analysis: PDGF-R Agonists and Antagonists
static version
printer friendly
pdf version
Competitor Analysis: Plk-1 Inhibitors
static version
printer friendly
pdf version
Competitor Analysis: PPAR Agonists
static version
printer friendly
pdf version
Competitor Analysis: Raf Inhibitors
static version
printer friendly
pdf version
Competitor Analysis: Sodium-Dependent Glucose (Co-) Transporter (SGLT)...
static version
printer friendly
pdf version
Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO)
static version
printer friendly
pdf version
Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists
static version
printer friendly
pdf version
Computational Chemistry: A Tool for Feeding R&D Pipelines
static version
printer friendly
pdf version
Concepts in Genetic Medicine
static version
printer friendly
pdf version
Conducting Clinical Trials in Emerging Markets
static version
printer friendly
pdf version
Contract Research Organization Market- What Pharmaceutical and Biotech...
static version
printer friendly
pdf version
COPD Drug Discovery: How New Generation Therapies Seek to Target Under...
static version
printer friendly
COX-2 Inhibitors - Biology, Therapeutic Agents & Markets
static version
printer friendly
COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact
static version
printer friendly
CRA Training Series (7 Volume Set) (2000)
static version
printer friendly
pdf version
CRA Training Series Vol. 1 - An Overview of Drug Development (2000)
static version
printer friendly
CRA Training Series Vol. 2 - Identifying and Screening Investigators (...
static version
printer friendly
CRA Training Series Vol. 3 - Conducting the Pre-Study Visit (2000)
static version
printer friendly
CRA Training Series Vol. 4 - Conducting the Study Initiation Visits (2...
static version
printer friendly
CRA Training Series Vol. 5 - Conducting Routine Monitoring Visits (200...
static version
printer friendly
CRA Training Series Vol. 6 - The CRA's Reference for Adverse Events (2...
static version
printer friendly
CRA Training Series Vol. 7 - Test Your Knowledge (2000)
static version
printer friendly
Current Clinical Trials: Rheumatology
static version
printer friendly
pdf version
Current Drug Development Market for Cytokines, Chemokines and Growth F...
static version
printer friendly
pdf version
^ Top
D
Dendritic Cells: Targets for Immunotherapy
static version
printer friendly
Development and Approval of Combination Products: A Regulatory Perspec...
static version
printer friendly
pdf version
Developments in Pharmaceutical Microencapsulation in the United States...
static version
printer friendly
pdf version
Disease and Therapy Review: Alzheimer's Disease
static version
printer friendly
pdf version
Disease and Therapy Review: Constipation
static version
printer friendly
pdf version
Disease and Therapy Review: Crohn's Disease
static version
printer friendly
pdf version
Disease and Therapy Review: End Stage Renal Disease
static version
printer friendly
pdf version
Disease and Therapy Review: High Cholesterol
static version
printer friendly
pdf version
Disease and Therapy Review: Irritable Bowel Syndrome
static version
printer friendly
pdf version
Disease and Therapy Review: Multiple Sclerosis
static version
printer friendly
pdf version
Disease and Therapy Review: Neuropathic Pain
static version
printer friendly
pdf version
Disease and Therapy Review: Rheumatoid Arthritis
static version
printer friendly
pdf version
Disease and Therapy Review: Schizophrenia
static version
printer friendly
pdf version
Disease and Therapy Review: Senile Dementia
static version
printer friendly
pdf version
Disease and Therapy Review: Systemic Lupus Erythematosus
static version
printer friendly
pdf version
Disease and Therapy Review: Urinary Incontinence
static version
printer friendly
pdf version
Does the Treatment of Huntington's Disease Represent a Commercial Oppo...
static version
printer friendly
pdf version
Drug Development Opportunities in China: Regulation, Key Players and I...
static version
printer friendly
pdf version
Drug Discovery for Nervous System Diseases
static version
printer friendly
pdf version
Drug Discovery Markets in Asia Pacific
static version
printer friendly
pdf version
Drug Discovery Outsourcing Market in India and China
static version
printer friendly
pdf version
Drug Discovery Research: New Frontiers in the Post-Genomic Era
static version
printer friendly
pdf version
Drug Discovery Technologies & Platforms - Speed up your preclinical re...
static version
printer friendly
Drug Discovery Technologies - A Global Update of Market Trends & Oppor...
static version
printer friendly
pdf version
Drug Discovery Technologies - Global Strategic Business Report
static version
printer friendly
pdf version
Drug Discovery Tools for High-Content Analysis
static version
printer friendly
pdf version
Drug Discovery--European Advances in Genomics and Proteomics (Technica...
static version
printer friendly
pdf version
Drug Discovery: A History
static version
printer friendly
Drug Efficacy, Safety, and Biologics Discovery: Emerging Technologies ...
static version
printer friendly
pdf version
Drug Metabolism Handbook: Concepts and Applications
static version
printer friendly
pdf version
Drug Metabolism in Drug Design and Development
static version
printer friendly
pdf version
Drug Registration In China-An overview of China Drug Registration Proc...
static version
printer friendly
pdf version
Drug Repositioning Strategies: Innovative Strategies to Boost Pipeline...
static version
printer friendly
pdf version
Drug Safety Evaluation, 2nd Edition
static version
printer friendly
pdf version
Drug Targets from Genomics: Evolving Tools for Discovery
static version
printer friendly
Drug-DNA Interactions: Structures and Spectra
static version
printer friendly
pdf version
Drug-Drug Interactions in Pharmaceutical Development
static version
printer friendly
pdf version
Drug-Induced Mitochondrial Dysfunction
static version
printer friendly
pdf version
Drugs for Medical Use Approved for Cosmetic Use
static version
printer friendly
pdf version
Drugs of Tommorow 2002: Breast Cancer
static version
printer friendly
Drugs of Tommorrow 2002: Pain
static version
printer friendly
pdf version
Drugs of Tomorrow 2000 Vaccines: A New Era of Disease Targets
static version
printer friendly
Drugs of Tomorrow 2000: Allergic Rhinitis - New Drug Classes, Towards ...
static version
printer friendly
pdf version
Drugs of Tomorrow 2000: Arthritis - Developments For a Competitive Mar...
static version
printer friendly
pdf version
Drugs of Tomorrow 2000: Lung Cancer - New Partners For Old Regimens
static version
printer friendly
Drugs of Tomorrow 2000: Prostate Cancer - Hormonals and Beyond
static version
printer friendly
Drugs of Tomorrow 2001: Anticoagulants - A pipeline flowing with futur...
static version
printer friendly
Drugs of Tomorrow 2001: Antipsychotics - New Players in an Expanding M...
static version
printer friendly
Drugs of Tomorrow 2001: Bacterial Infections
static version
printer friendly
Drugs of Tomorrow 2001: Cancer Overview
static version
printer friendly
Drugs of Tomorrow 2001: Depression - A Future Away From Serotonin?
static version
printer friendly
Drugs of Tomorrow 2001: Diabetes
static version
printer friendly
Drugs of Tomorrow 2001: Dyslipidemia - The Advent of Third Generation ...
static version
printer friendly
Drugs of Tomorrow 2001: Hepatitis - The Succession of New Generation T...
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Hypertension - The Mounting Pressures Facing N...
static version
printer friendly
Drugs of Tomorrow 2001: Lung Cancer
static version
printer friendly
Drugs of Tomorrow 2001: Migraine - Impact of the Novel Triptan Class o...
static version
printer friendly
Drugs of Tomorrow 2001: Neuroprotection - Future Strategies for Succes...
static version
printer friendly
Drugs of Tomorrow 2001: Stable Angina - An Unsatisfactory R&D Pipeline...
static version
printer friendly
Drugs of Tomorrow 2002: Arthritis
static version
printer friendly
pdf version
Drugs of Tomorrow 2002: Colorectal Cancer
static version
printer friendly
Drugs of Tomorrow 2002: Depression - A pipeline driven by side effect ...
static version
printer friendly
pdf version
Drugs of Tomorrow 2002: Reperfusion Injury - The Next Breakthrough in ...
static version
printer friendly
Drugs of Tomorrow: Anti-asthmatics - Enter the mAbs
static version
printer friendly
Drugs of Tomorrow: Cancer Overview
static version
printer friendly
Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovati...
static version
printer friendly
Drugs: From Discovery to Approval, 2nd Edition
static version
printer friendly
Due Diligence in Life Science Transactions, 2nd Edition
static version
printer friendly
pdf version
^ Top
E
Early Stage Drug Safety Strategies and Risk Management: Maximizing Opp...
static version
printer friendly
pdf version
Emerging Drug Discovery Technologies: Building competitive advantage t...
static version
printer friendly
Emerging Drug Targets in Alzheimer's Disease
static version
printer friendly
pdf version
Emerging Opportunities in Controlled-Release Generic Drugs
static version
printer friendly
pdf version
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs
static version
printer friendly
pdf version
Emerging Opportunities with Cannabinoids
static version
printer friendly
pdf version
Emerging Pharmaceutical Markets: Growth Opportunities, Changing Health...
static version
printer friendly
pdf version
Ethical Issues in Drug Development:A Deterrent To Fraud and other Malf...
static version
printer friendly
pdf version
European Cell Based Assays Markets
static version
printer friendly
pdf version
European Generic Drug Market Potential
static version
printer friendly
pdf version
European Urinary Incontinence Therapeutics Markets
static version
printer friendly
pdf version
^ Top
F
Formulation and Analytical Development for Low-Dose Oral Drug Products...
static version
printer friendly
pdf version
Fragment-Based Drug Discovery: A Practical Approach
static version
printer friendly
pdf version
Fueling the Drug Discovery Engine: Biotech Investment and Business Tre...
static version
printer friendly
pdf version
^ Top
G
G-Protein Coupled Receptors (GPCRs): Technical Overview, Emerging Tech...
static version
printer friendly
Gastrointestinal Drug Discoveries: What the Future Holds
static version
printer friendly
pdf version
Generic Series: Benchmarking Patent Expiries - Key Factors Affecting B...
static version
printer friendly
pdf version
Genomics in Drug Discovery and Development
static version
printer friendly
pdf version
Genomics Players: From Discovery to Integration- Business and Technolo...
static version
printer friendly
pdf version
Genomics: Pharmaceutical Investment, Integration and Partnerships
static version
printer friendly
Global Market for Plant Derived Drugs, 2005-2012
static version
printer friendly
pdf version
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery ...
static version
printer friendly
pdf version
Glycogen synthase kinase 3 inhibitors: Proof of concept and therapeuti...
static version
printer friendly
^ Top
H
Herg: Technology and Market Analysis
static version
printer friendly
High Content Screening: Science, Techniques and Applications
static version
printer friendly
pdf version
High-tech immunization
static version
printer friendly
How Overcoming the Challenge of Biomarker Validation Can Pay Off for D...
static version
printer friendly
pdf version
Hypoglycaemia in Clinical Diabetes, 2nd Edition
static version
printer friendly
pdf version
^ Top
I
Iminosugars: From Synthesis to Therapeutic Applications
static version
printer friendly
pdf version
Indian Bulk Drugs
static version
printer friendly
pdf version
Industry Analysis - Changing Dynamics in Worldwide Psychiatric Franchi...
static version
printer friendly
pdf version
Innovations in Cardiovascular Disease Management: Latest Surgical Proc...
static version
printer friendly
pdf version
Innovative Strategies and Models for R&D Success: The Evolving Network...
static version
printer friendly
pdf version
Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Dru...
static version
printer friendly
pdf version
Investigator-Initiated Trials: Building Superior IIT Capabilities
static version
printer friendly
pdf version
Ion Channel Assays in the Drug Discovery Process
static version
printer friendly
IT Software Tools for Life Science and Drug Discovery R&D
static version
printer friendly
pdf version
^ Top
K
Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerg...
static version
printer friendly
pdf version
KeywordPharma Conference Insights - Accelerating Patient Recruitment i...
static version
printer friendly
pdf version
Knowledge Management Tools for Drug Discovery
static version
printer friendly
pdf version
^ Top
L
Licensing in Antibacterial R&D - Filling the Gaps
static version
printer friendly
^ Top
M
Male and female sexual dysfunction: Blockbuster indication for multipl...
static version
printer friendly
Market Opportunities and Challenges for Antibody Arrays and Beads: A M...
static version
printer friendly
Market Research of Diabetes and its Treatment Medicine-Insulin in Chin...
static version
printer friendly
pdf version
Mass Spectrometry in Drug Metabolism and Pharmacokinetics
static version
printer friendly
pdf version
Mastering Phase IV Clinical Trials
static version
printer friendly
pdf version
Maximizing R&D Productivity: Getting More Bang For Your R&D Buck
static version
printer friendly
pdf version
Medication Reconciliation Strategies to Reduce Hospital Adverse Drug E...
static version
printer friendly
pdf version
Medicinal Chemistry: An Introduction, 2nd Edition
static version
printer friendly
pdf version
Melanoma Therapeutics: Which Strategy Will Take Us There?
static version
printer friendly
Model Organisms in Drug Discovery and Development: An Industry Analys...
static version
printer friendly
Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and D...
static version
printer friendly
Molecular Therapeutics: 21st Century Medicine
static version
printer friendly
pdf version
^ Top
N
Nanotechnology for Drug Discovery and Drug Design
static version
printer friendly
Narrowing the Innovation Gap with Fragment-Based Drug Discovery and De...
static version
printer friendly
pdf version
Navigating the Drug Discovery Landscape: A Strategic Overview of Pharm...
static version
printer friendly
pdf version
Neurological Disease: Early-Stage R&D and Dealmaking
static version
printer friendly
pdf version
New Drug Development: A Regulatory Overview (8th Edition)
static version
printer friendly
pdf version
New Drug Discovery and Development
static version
printer friendly
pdf version
New Options for Treating Neurological Disease: Stem Cell Therapy
static version
printer friendly
pdf version
New Strategies Combating Bacterial Infection
static version
printer friendly
pdf version
Next Generation Drugs: Acceleration Through Innovation
static version
printer friendly
Next-Generation Biologics: Improving on Monoclonal Antibodies
static version
printer friendly
pdf version
Next-Generation Genome Sequencing : Towards Personalized Medicine
static version
printer friendly
pdf version
Novel Targets in Drug Discovery
static version
printer friendly
pdf version
Nuclear Receptors in Drug Metabolism
static version
printer friendly
pdf version
Number of Drugs in Preclinical Testing by Year, 1995-2004
static version
printer friendly
pdf version
Nutrition: Science and Applications with Booklet Package
static version
printer friendly
pdf version
^ Top
O
Obesity Drug Discoveries: What the Future Holds
static version
printer friendly
pdf version
Obesity Drug Discoveries: What The Future Holds + Obesity Tracker
static version
printer friendly
pdf version
Obesity Drug Discovery: Success and Challenges for a New Pharmaceutica...
static version
printer friendly
pdf version
Obesity Therapeutics: Understanding Market Dynamics (Presentation)
static version
printer friendly
pdf version
Opportunities for Bioinformatics in European Drug Discovery Markets
static version
printer friendly
pdf version
Optimizing the Clinical Trial Process: Strategies to Reduce Costs and ...
static version
printer friendly
Outlook for the Migraine Market With Novel Approaches Limited, Triptan...
static version
printer friendly
pdf version
Outsourcing Drug Discovery to China and India
static version
printer friendly
pdf version
Outsourcing Opportunities in India and China (Two Reports)
static version
printer friendly
pdf version
Overcoming Challenges in Antibacterial Drug Discovery and Development
static version
printer friendly
pdf version
Overview of the European Drug Discovery Market
static version
printer friendly
pdf version
^ Top
P
Partnership in Clinical Trials: Pharmaceutical Company and Managed Car...
static version
printer friendly
Patent Protection Strategies: Maximising Product Revenues
static version
printer friendly
pdf version
Pathway Analysis for Drug Discovery: Computational Infrastructure and ...
static version
printer friendly
pdf version
Pediatric Drug Development: Concepts and Applications
static version
printer friendly
pdf version
Peptides as Drugs: Discovery and Development
static version
printer friendly
pdf version
Peripheral Neuropathy and Neuropathic Pain
static version
printer friendly
pdf version
Personalized Medicine: The Impact of Pharmacogenomics on Pharmaceutica...
static version
printer friendly
Pharma R&D: Lessons Learned for Future Growth
static version
printer friendly
Pharmaceutical Innovation: An Analysis Of Leading Companies And Strate...
static version
printer friendly
pdf version
Pharmaceutical R&D Outsourcing Strategies: An Analysis of Market Drive...
static version
printer friendly
pdf version
Pharmacogenomics for Clinical Use and in Drug Development
static version
printer friendly
pdf version
Pipeline Insight: ADHD - Shire Driving Diversity in ADHD
static version
printer friendly
Pipeline Insight: Antithrombotics - Reaching The Untreated Prophylaxis...
static version
printer friendly
pdf version
Pipeline Insight: Asthma/COPD/Allergic Rhinitis - As Patents Expire, N...
static version
printer friendly
Pipeline Insight: Disease Modification In Rheumatoid Arthritis - Compe...
static version
printer friendly
pdf version
Pipeline Insight: Dyslipidemia - Pipeline Agents Unlikely To Rejuvenat...
static version
printer friendly
pdf version
Pipeline Insight: Hepatitis B - New Kids On The Block
static version
printer friendly
Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution
static version
printer friendly
Pipeline Insight: Insomnia - Targeting The Sleep Maintenance Market
static version
printer friendly
pdf version
Pipeline Insight: Neuropathic Pain - Pipeline Drugs Fail To Nail Neuro...
static version
printer friendly
pdf version
Post Genome Project Era Proteomics R&D Competition
static version
printer friendly
Post-ADA Report - Coverage and Analysis of Highlighted Data Presented ...
static version
printer friendly
pdf version
Preclinical Safety Evaluation of Biopharmaceuticals: A Science-Based A...
static version
printer friendly
pdf version
Prospects for the Phase III Bapineuzumab Trial
static version
printer friendly
pdf version
Proteases as Drug Targets: Technologies and Opportunities for Drug Dis...
static version
printer friendly
Protein Arrays: Commercial Opportunities, Legal Trends, and Technology...
static version
printer friendly
pdf version
Protein Targeting with Small Molecules: Chemical Biology Techniques an...
static version
printer friendly
pdf version
Psychiatric Drugs: New Developments and Market Analysis by Drug Class ...
static version
printer friendly
^ Top
R
R and D Ratios and Budgets
static version
printer friendly
R&D Pipeline News - Technology Edition
static version
printer friendly
pdf version
R&D Pipeline News - Therapeutic Area Edition
static version
printer friendly
pdf version
R&D Update: What's on the Horizon for the Panic Disorder Market?
static version
printer friendly
pdf version
Rapid Viral Testing
static version
printer friendly
Regulatory Hurdles in European Drug Discovery
static version
printer friendly
pdf version
Repositioning ADME Studies: A Strategy to Reduce Drug Attrition
static version
printer friendly
pdf version
Research and Development Growth Trends
static version
printer friendly
Retinoids : An A-Z guide to their biology, therapeutic opportunities a...
static version
printer friendly
Revenue Structure and Contract Models for Transgenic Manufacturing and...
static version
printer friendly
Rheumatoid Arthritis Drug Discoveries: What The Future Holds
static version
printer friendly
pdf version
RNA Interference for Drug R&D: Applications, Alliances, Companies and ...
static version
printer friendly
pdf version
RNAi: Broad Application, Expansive Opportunity, 2nd Edition
static version
printer friendly
pdf version
^ Top
S
Sector Snapshot: Contract Drug Discovery Industry
static version
printer friendly
pdf version
SNP Detection: Developing Technologies and Market Strategies
static version
printer friendly
Solving Drug Discovery with Metabolomics and Metabonomics: New Aspects...
static version
printer friendly
pdf version
Statistical Issues in Drug Development, 2nd Edition
static version
printer friendly
pdf version
Strategic Analysis of Drug Discovery Outsourcing Markets in Europe
static version
printer friendly
pdf version
Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Di...
static version
printer friendly
pdf version
Strategic Analysis of Pharmaceutical Excipients Market in Europe
static version
printer friendly
pdf version
Strategic Analysis of the ADME/TOX Technologies Market in Europe
static version
printer friendly
pdf version
Strategic Analysis of the Age-Related Macular Degeneration; Diabetic R...
static version
printer friendly
pdf version
Strategic Analysis of World Combinatorial Chemistry Markets
static version
printer friendly
pdf version
Strategic Analysis of World Drug Discovery Spending
static version
printer friendly
pdf version
Strategic Analysis of World Emerging Neurological Therapeutics Markets...
static version
printer friendly
pdf version
Strategic Assessment of HTS in the Asia Pacific Life Sciences Market
static version
printer friendly
pdf version
Strategic Perspectives 2001: Ovarian Cancer - Overview of Current and ...
static version
printer friendly
pdf version
Strategic Perspectives: Non-Hodgkin’s Lymphoma A Market Galvanized by ...
static version
printer friendly
Streamlining Clinical Trials
static version
printer friendly
pdf version
Structure, Function and Modulation of Neuronal Voltage-Gated Ion Chann...
static version
printer friendly
pdf version
Structure-Guided Drug Design: Rediscovering the Importance of Drug Str...
static version
printer friendly
Synthetic Biology: An Emerging Tool for Drug Discovery and Production
static version
printer friendly
pdf version
^ Top
T
Targeting endogenous inhibitors of apoptosis: Opportunities for the tr...
static version
printer friendly
Targeting Kinases for Drug Discovery
static version
printer friendly
pdf version
Technology Meets Drug Discovery: The Bioinformatics Revolution
static version
printer friendly
The Anemia Market: Biogenerics and Second-Generation Products Drive Ch...
static version
printer friendly
pdf version
The Blockbuster Drugs Outlook: Optimum management strategies throughou...
static version
printer friendly
pdf version
The Drug Delivery Outlook 2001
static version
printer friendly
pdf version
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
static version
printer friendly
The Emerging Role of Postmarketing Clinical Research: Regulatory issue...
static version
printer friendly
pdf version
The Future of Biobanks: Regulation, Ethics, Investment and the Humaniz...
static version
printer friendly
pdf version
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
static version
printer friendly
pdf version
The Genomics Outlook To 2005: Transforming Pharmaceutical And Diagnost...
static version
printer friendly
The Global Bioinformatics Industry
static version
printer friendly
pdf version
The Global Functional Genomics Industry
static version
printer friendly
The Organic Chemistry of Drug Synthesis, Volume 7
static version
printer friendly
pdf version
The Role of Nanotechnology in European Drug Discovery
static version
printer friendly
pdf version
The Top 10 Contract Research Organizations: Positioning, Performance a...
static version
printer friendly
pdf version
The Top 100 Contract Research Organisations In Europe
static version
printer friendly
pdf version
The Top 20 Contract Research Organisations In Eastern Europe
static version
printer friendly
pdf version
The Top 20 Contract Research Organisations In Europe For Ophthalmic Di...
static version
printer friendly
pdf version
The Top 20 Contract Research Organisations In The United Kingdom
static version
printer friendly
pdf version
The Top 25 Contract Research Organisations In Germany & France
static version
printer friendly
pdf version
The Top 50 Contract Research Organisations In Europe For Cardiovascula...
static version
printer friendly
pdf version
The Transgenic Plant Market: Profits from New Products and Novel Drugs...
static version
printer friendly
The Virtual Genome: From Genes to Drugs Via the Internet
static version
printer friendly
Therapeutic and Pharmaceutical Opportunities for Osteoporosis and Athe...
static version
printer friendly
pdf version
Therapeutic Clinical Intelligence - Psoriasis
static version
printer friendly
pdf version
Therapeutic protein industry - value mapping
static version
printer friendly
pdf version
Therapeutic Vaccines for Cancer: On the Threshold of Success
static version
printer friendly
Tissue MicroArrays: Emerging Business Opportunities and Applications D...
static version
printer friendly
Transforming Clinical Development Performance through Benchmarking and...
static version
printer friendly
Transforming Drug Discovery through Genomics and Proteomics
static version
printer friendly
pdf version
Translational Medicine in Biopharmaceutical R&D: Enabling R&D Optimiza...
static version
printer friendly
pdf version
Trends in Diabetes Treatments and Obesity
static version
printer friendly
pdf version
^ Top
U
U.S. ADME/Tox in Drug Development Markets
static version
printer friendly
pdf version
U.S. Next Generation Bio-Tools for Accelerating Bio-Pharmaceutical Dru...
static version
printer friendly
Understanding Chiral Technologies
static version
printer friendly
pdf version
Uniting R&D and Marketing for Integrated Early-Stage Market Preparatio...
static version
printer friendly
pdf version
^ Top
V
Vaccine Adjuvants and Delivery Systems
static version
printer friendly
pdf version
Virtual Screening Opportunities in Drug Discovery in Europe
static version
printer friendly
pdf version
^ Top
W
What Is the Future Role of Predictive Safety Biomarkers in Drug Develo...
static version
printer friendly
pdf version
World ADME/Tox in Drug Development Markets
static version
printer friendly
pdf version
World Drug Discovery Contract Research Markets - A Strategic Analysis ...
static version
printer friendly
pdf version
World Drug Discovery Contract Research Markets: Profiles of the Top 50...
static version
printer friendly
pdf version
World Drug Discovery Technologies Markets Outlook
static version
printer friendly
pdf version
World Market for Drug Discovery Informatics, 2004-2010
static version
printer friendly
pdf version
World Robotics in Biology: Liquid Handling Markets
static version
printer friendly
pdf version
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug D...
static version
printer friendly
pdf version
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug D...
static version
printer friendly
pdf version
Worldwide Drug Discovery R&D
static version
printer friendly
All rights reserved. © copyright 2008 Research and Markets
Terms and conditions
Privacy Policy